USP8 and hepatocellular carcinoma: Consistent with RTKs inhibition, we observed a significant reduction of p-Akt, p-STAT3 and p-Raf (Figure 5), confirming that USP8 inhibition targets multiple RTKs in HCC, which is in agreement with previous reports [13–15].